Vigabatrin therapy in patient with succinic semialdehyde dehydrogenase deficiencyGIBSON, K. M; DEVIVO, D. C; JAKOBS, C et al.Lancet (British edition). 1989, Vol 2, Num 8671, pp 1105-1106, issn 0140-6736, 2 p.Article

Effect of Vigabatrin on motor responses to transcranial magnetic stimulation: An effective tool to investigate in vivo GABAergic cortical inhibition in humansPIERANTOZZI, Mariangela; MARCIANI, Maria Grazia; PALMIERI, Maria Giuseppina et al.Brain research. 2004, Vol 1028, Num 1, pp 1-8, issn 0006-8993, 8 p.Article

Tiagabine and vigabatrin reduce the severity of NMDA-induced excitotoxicity in chick retinaPISANI, Francesco; COSTA, Cinzia; CACCAMO, Daniela et al.Experimental brain research. 2006, Vol 171, Num 4, pp 511-515, issn 0014-4819, 5 p.Article

Vigabatrin, Lamotrigine, Topiramate and Serum Carnitine LevelsZEINIK, Nathanel; ISLER, Naomi; GOEZ, Helly et al.Pediatric neurology. 2008, Vol 39, Num 1, pp 18-21, issn 0887-8994, 4 p.Article

Are vigabatrin-associated visual field constrictions asymptomatic?SCHMIDT, T; RÜTHER, K; SCHMITZ, B et al.Journal of neurology. 2004, Vol 251, Num 7, pp 887-888, issn 0340-5354, 2 p.Article

Peripheral retinal dysfunction in patients taking vigabatrinMCDONAGH, J; STEPHEN, L. J; DOLAN, F. M et al.Neurology. 2003, Vol 61, Num 12, pp 1690-1694, issn 0028-3878, 5 p.Article

Outer retinal dysfunction in patients treated with vigabatrinARNDT, C. F; DERAMBURE, P; DEFOORT-DHELLEMMES, S et al.Neurology. 1999, Vol 52, Num 6, pp 1201-1205, issn 0028-3878Article

Visual field defects in pediatric patients on vigabatrin monotherapyASCASO, Francisco J; LOPEZ, Maria J; MAURI, José A et al.Documenta ophthalmologica. 2003, Vol 107, Num 2, pp 127-130, issn 0012-4486, 4 p.Article

The effects of vigabatrin on type II spike wave discharges in ratsBOUWMAN, Brigitte M; VAN DEN BROEK, Philip L. C; VAN LUIJTELAAR, Gilles et al.Neuroscience letters. 2003, Vol 338, Num 3, pp 177-180, issn 0304-3940, 4 p.Article

Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramateÄNGEHAGEN, Mikael; BEN-MENACHEM, Elinor; RÖNNBÄCK, Lars et al.Neurochemical research. 2003, Vol 28, Num 2, pp 333-340, issn 0364-3190, 8 p.Article

Reversible motor disturbances induced by vigabatrinJONGSMA, M. J; LAAN, L. A. E. M; VAN EMDE BOAS, W et al.Lancet (British edition). 1991, Vol 338, Num 8771, issn 0140-6736, p. 893Article

Vigabartin as spasmolytic drugJAEKEN, J; DE COCK, P; CASAER, P et al.Lancet (British edition). 1991, Vol 338, Num 8782-3, issn 0140-6736, p. 1603Article

Simultaneous isocratic HPLC determination of vigabatrin and gabapentin in human plasma by dansyl derivatizationKRIVANEK, Peter; KOPPATZ, Karl; TURNHEIM, Klaus et al.Therapeutic drug monitoring. 2003, Vol 25, Num 3, pp 374-377, issn 0163-4356, 4 p.Article

Capillary electrophoresis enantioselective separation of vigabatrin enantiomers by precolumn derivatization with dehydroabietylisothiocyante and UV-vis detectionSHULIN ZHAO; RONGCAN ZHANG; HENGSHAN WANG et al.Journal of chromatography. B. 2006, Vol 833, Num 2, pp 186-190, issn 1570-0232, 5 p.Article

Visual defects associated with vigabatrin : A study of epileptic argentine patientsMORENO, Maria Cecilia; GIAGANTE, Brenda; SAIDON, Patricia et al.Canadian journal of neurological sciences. 2005, Vol 32, Num 4, pp 459-464, issn 0317-1671, 6 p.Article

Fast isocratic high-performance liquid chromatographic assay method for the simultaneous determination of gabapentin and vigabatrin in human serumCHOLLET, Daniel F; GOUMAZ, Laurent; JULIANO, Corinne et al.Journal of chromatography. B, Biomedical sciences and applications. 2000, Vol 746, Num 2, pp 311-314, issn 1387-2273Article

Atteintes du champ visuel dues au vigabatrin = Visual field constriction associated with vigabatrinLa Revue Prescrire. 1999, Vol 19, Num 199, pp 679-680, issn 0247-7750Article

Retinal Nerve Fiber Layer Thickness in Vigabatrin-Exposed PatientsCLAYTON, Lisa M; DEVILE, Marita; PUNTE, Trusjen et al.Annals of neurology. 2011, Vol 69, Num 5, pp 845-854, issn 0364-5134, 10 p.Article

Determination of vigabatrin by capillary electrophoresis with laser-induced fluorescence detectionCHANG, Sarah Y; LIN, Wen-Chung.Journal of chromatography. B. 2003, Vol 794, Num 1, pp 17-22, issn 1570-0232, 6 p.Article

Visual field defect associated with vigabatrin : observational cohort studyWILTON, L. V; STEPHENS, M. D. B; MANN, R. D et al.BMJ. British medical journal (International ed.). 1999, Vol 319, Num 7218, pp 1165-1166, issn 0959-8146Article

A limited sampling method for the estimation of vigabatrin maximum plasma concentration and area under the curveTAMMARA, V; MAHMOOD, I; YU, D. K et al.Therapeutic drug monitoring. 1997, Vol 19, Num 1, pp 79-82, issn 0163-4356Article

Visual field constriction associated with vigabatrin: retinal nerve fiber layer photographic correlationCHOI, H. J; KIM, D. M.Journal of neurology, neurosurgery and psychiatry. 2004, Vol 75, Num 10, issn 0022-3050, p. 1395Article

Vigabatrin-induced modification of Ki-67 expression in gingival epithelium: immunohistochemical study of a short seriesMESA, F; AGUILA, M; GONZALEZ-MOLES, M. A et al.Journal of periodontal research. 2004, Vol 39, Num 1, pp 66-71, issn 0022-3484, 6 p.Article

Vigabatrin for Childhood Partial-Onset EpilepsiesGREINER, Hansel M; LYNCH, Elizabeth R; FORDYCE, Steve et al.Pediatric neurology. 2012, Vol 46, Num 2, pp 83-88, issn 0887-8994, 6 p.Article

New antiepileptic drugsBOURGEOIS, B. F. D.Archives of neurology (Chicago). 1998, Vol 55, Num 9, pp 1181-1183, issn 0003-9942Article